NPY1-R activators, in this context, refer to compounds that can indirectly influence the activity of the Neuropeptide Y1 receptor. This receptor plays a critical role in various physiological processes and is primarily activated by Neuropeptide Y (NPY), its endogenous ligand. The list includes NPY itself and related peptides like Peptide YY (PYY) and Pancreatic Polypeptide (PP), which share structural similarities with NPY and can interact with NPY1-R. These peptides, though they vary in their affinity and specificity for NPY1-R, provide a foundation for understanding the receptor's activation mechanism.
The inclusion of antagonists such as BIBP 3226, GW1229, CGP 71683, PD 160170, LY303870, and JNJ-31020028 is significant for studying the receptor's dynamics. While these compounds are inhibitors, their interaction with NPY1-R helps elucidate the receptor's binding sites and activation processes. This information is crucial in developing synthetic activators or modulators of NPY1-R. Furthermore, [Leu31, Pro34]-Neuropeptide Y, a synthetic analog of NPY, serves as a tool for investigating the receptor's activation and signaling pathways. The interaction of NPY1-R with its ligands and antagonists, and the subsequent signaling cascades, are essential for understanding the physiological roles of the receptor.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
CGP 71683 hydrochloride | 192322-50-2 | sc-203881 sc-203881A sc-203881B | 10 mg 50 mg 1 g | $209.00 $862.00 $1320.00 | ||
A selective NPY1-R antagonist that can be useful in studying the receptor's activation and signaling. | ||||||
AMD 3465 hexahydrobromide | 185991-07-5 | sc-362709 sc-362709A | 10 mg 50 mg | $185.00 $772.00 | ||
An antagonist for NPY1-R, useful in research on receptor activation and signaling pathways. | ||||||